Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Ellis

Showing results (881-890 of 1,150) with videos related to

Pageof 115
Sort By:
The American Journal of Cardiology|December 11, 1991
Causes and correlates of death after unsupported coronary angioplasty: implications for use of angioplasty and advanced support techniques in high-risk settingsS G Ellis, R K Myler, S B King, et al.
The Plant Cell|January 9, 2016
Comparative Analysis of the Flax Immune Receptors L6 and L7 Suggests an Equilibrium-Based Switch Activation ModelMaud Bernoux, Hayden Burdett, Simon J Williams, et al.
Plos One|December 9, 2014
Genome-wide linkage scan identifies two novel genetic loci for coronary artery disease: in GeneQuest familiesHanxiang Gao, Lin Li, Shaoqi Rao, et al.
JAMA|August 21, 2003
Prevalence of conventional risk factors in patients with coronary heart diseaseUmesh N Khot, Monica B Khot, Christopher T Bajzer, et al.
Neurology|July 27, 2001
Presynaptic congenital myasthenic syndrome due to quantal release deficiencyR A Maselli, D Z Kong, C M Bowe, et al.
The Journal of Invasive Cardiology|November 4, 2000
Unexpected mortality reduction with abciximab for in-stent restenosisD Mukherjee, J P Reginelli, D J Moliterno, et al.
Circulation|March 1, 1994
Major clinical events after coronary stenting. The multicenter registry of acute and elective Gianturco-Roubin stent placement. The Gianturco-Roubin Intracoronary Stent Investigator GroupJ M Sutton, S G Ellis, G S Roubin, et al.
Journal of the American College of Cardiology|February 1, 1991
A randomized placebo-controlled trial of combined early intravenous captopril and recombinant tissue-type plasminogen activator therapy in acute myocardial infarctionE G Nabel, E J Topol, A Galeana, et al.
HIV Clinical Trials|October 30, 2018
Association of raltegravir use with long-term health outcomes in HIV-infected patients: an observational post-licensure safety study in a large integrated healthcare systemMichael A Horberg, Allison H Oakes, Leo B Hurley, et al.
Clinical Pharmacology and Therapeutics|August 2, 2002
A target-mediated model to describe the pharmacokinetics and hemodynamic effects of recombinant human vascular endothelial growth factor in humansStephen M Eppler, Daniel L Combs, Timothy D Henry, et al.
Pageof 115

Showing results (881-890 of 1,150) with videos related to

Sort By:
Pageof 115
The American Journal of Cardiology|December 11, 1991
Causes and correlates of death after unsupported coronary angioplasty: implications for use of angioplasty and advanced support techniques in high-risk settingsS G Ellis, R K Myler, S B King, et al.
The Plant Cell|January 9, 2016
Comparative Analysis of the Flax Immune Receptors L6 and L7 Suggests an Equilibrium-Based Switch Activation ModelMaud Bernoux, Hayden Burdett, Simon J Williams, et al.
Plos One|December 9, 2014
Genome-wide linkage scan identifies two novel genetic loci for coronary artery disease: in GeneQuest familiesHanxiang Gao, Lin Li, Shaoqi Rao, et al.
JAMA|August 21, 2003
Prevalence of conventional risk factors in patients with coronary heart diseaseUmesh N Khot, Monica B Khot, Christopher T Bajzer, et al.
Neurology|July 27, 2001
Presynaptic congenital myasthenic syndrome due to quantal release deficiencyR A Maselli, D Z Kong, C M Bowe, et al.
The Journal of Invasive Cardiology|November 4, 2000
Unexpected mortality reduction with abciximab for in-stent restenosisD Mukherjee, J P Reginelli, D J Moliterno, et al.
Circulation|March 1, 1994
Major clinical events after coronary stenting. The multicenter registry of acute and elective Gianturco-Roubin stent placement. The Gianturco-Roubin Intracoronary Stent Investigator GroupJ M Sutton, S G Ellis, G S Roubin, et al.
Journal of the American College of Cardiology|February 1, 1991
A randomized placebo-controlled trial of combined early intravenous captopril and recombinant tissue-type plasminogen activator therapy in acute myocardial infarctionE G Nabel, E J Topol, A Galeana, et al.
HIV Clinical Trials|October 30, 2018
Association of raltegravir use with long-term health outcomes in HIV-infected patients: an observational post-licensure safety study in a large integrated healthcare systemMichael A Horberg, Allison H Oakes, Leo B Hurley, et al.
Clinical Pharmacology and Therapeutics|August 2, 2002
A target-mediated model to describe the pharmacokinetics and hemodynamic effects of recombinant human vascular endothelial growth factor in humansStephen M Eppler, Daniel L Combs, Timothy D Henry, et al.
Pageof 115